Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-01-31 @ 2:43 PM
Study NCT ID:
NCT07115095
Status:
COMPLETED
Last Update Posted:
2025-08-11
First Post:
2025-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer
Sponsor:
Nanlin Li
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2-positive Breast Cancer | View |
Keywords: